Zhongguo quanke yixue (Dec 2024)

Interpretation of the Use of Artificial Intelligence in Improving Outcomes in Heart Disease：a Scientific Statement from the American Heart Association

  • ZHOU Yiheng, YANG Ziyu, LYU Yao, LIU Lidi, SHEN Can, LIAO Xiaoyang, JIA Yu

DOI
https://doi.org/10.12114/j.issn.1007-9572.2024.0192
Journal volume & issue
Vol. 27, no. 35
pp. 4353 – 4357

Abstract

Read online

Artificial Intelligence (AI) is an emerging technology to improve healthcare services. With the joint promotion of government agencies and academic departments around the world, a large number of studies have demonstrated that AI can improve the diagnosis, treatment and prevention of cardiovascular disease. However, there are still some limitations in its development and application, and it has not yet been widely used in clinical practice. Based on this, the American Heart Association (AHA) published the Use of Artificial Intelligence in Improving Outcomes in Heart Disease: a Scientific Statement from the American Heart Association in Circulation on April 2, 2024. This statement reviews the research progress of AI in the diagnosis, classification and treatment of cardiovascular disease, puts forward the existing problems and potential solutions, and builds a framework for the future application of AI in the cardiovascular disease. This article aims to interpret the statement for providing advice and direction for the application and research of AI in cardiovascular disease in China.

Keywords